SecBot SecBot
SECBOTREPLAY Home › Report › CGON

CGON · Director Leonard Post filed a Form 144 notice of intent to sell 5,000…

CG Oncology, Inc. · 144 filed Jun 24, 2026 at 16:37 ET

At the news

NEUTRALIMPACT 2/10

144 filed Jun 24, 2026 at 16:37 ET

Director Leonard Post filed a Form 144 notice of intent to sell 5,000 shares of CG Oncology common stock, with an estimated aggregate market value of $328,650. The shares are to be acquired through the exercise of stock options, and the sale is planned under a Rule 10b5-1 trading plan. This is a routine insider sale by a director, not a top executive, and the dollar amount is small relative to the company's $6.1B market cap.

  • Director Leonard Post filed Form 144 on June 24, 2026, indicating intent to sell 5,000 shares.
  • Estimated aggregate market value of the proposed sale is $328,650.
  • Shares are to be acquired upon exercise of stock options; sale is part of a pre-arranged 10b5-1 plan.
  • The sale represents a tiny fraction of the company's $6.1B market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access